Longevity and Clinical Effectiveness of the Humoral and Cellular Responses to SARS-CoV-2 Vaccination in Hemodialysis Patients.

De Vriese, An S; Van Praet, Jens; Reynders, Marijke; Heylen, Line; Viaene, Liesbeth; Caluwé, Rogier; Schoutteten, Melanie; De Bacquer, Dirk

De Vriese, An S; Van Praet, Jens; Reynders, Marijke; Heylen, Line; Viaene, Liesbeth; Caluwé, Rogier; Schoutteten, Melanie; De Bacquer, Dirk.

De Vriese AS; Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Van Praet J; Department of Internal Medicine, Ghent University, Ghent, Belgium.
Reynders M; Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Heylen L; Department of Internal Medicine, Ghent University, Ghent, Belgium.
Viaene L; Division of Medical Microbiology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Caluwé R; Division of Nephrology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Schoutteten M; Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
De Bacquer D; Division of Nephrology, AZ Groeninge, Kortrijk, Belgium.

Kidney Int Rep ; 7(5): 1103-1107, 2022 May.

Article in English | MEDLINE | ID: covidwho-1828435

Keywords

COVID-19; SARS-CoV-2; cellular; hemodialysis; immune response; longevity; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Topics: Vaccines Language: English Journal: Kidney Int Rep Year: 2022 Document Type: Article Affiliation country: J.ekir.2022.02.007

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google